Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.

Modern rheumatology - 1 Jan 2008

Nakamura Tadashi

Abstract excerpt

Secondary amyloid A (AA) amyloidosis is an important complication of rheumatoid arthritis (RA) and has remarkable variation in frequency worldwide. It is a serious, potentially life-threatening disorder caused by deposition in organs of AA fibrils, which are derived from the circulatory, acute-phase-reactant, serum amyloid A protein (SAA). The SAA1.3 allele can serve not only as a risk factor for the association...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arthritis, Rheumatoid
Share to Alleles
Share to Amyloidosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Antirheumatic Agents

Share to Etanercept

Share to Immunoglobulin G

Share to Receptors, Tumor Necrosis Factor

Share to Serum Amyloid A Protein

Source

Identifiers

PMID: 18369528
DOI: 10.1007/s10165-008-0035-2

Genes

SAA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis.PMID 18369528Read ↗

Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

Ageing: a risk factor for amyloid A amyloidosis in rheumatoid arthritis.Semantic proximity Read ↗

SAA1 gene polymorphisms and the risk of AA amyloidosis in Japanese patients with rheumatoid arthritis.Semantic proximity Read ↗

Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis.Semantic proximity Read ↗

Abdominal fat aspiration biopsy and genotyping of serum amyloid A contribute to early diagnosis of reactive AA amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview.Semantic proximity Read ↗

SAA1 alleles as risk factors in reactive systemic AA amyloidosis.Semantic proximity Read ↗

A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis.Semantic proximity Read ↗

HLA-DRB1*04 alleles in Japanese rheumatoid arthritis patients with AA amyloidosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.